Xiaoyi Shi

760 total citations
35 papers, 429 citations indexed

About

Xiaoyi Shi is a scholar working on Molecular Biology, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xiaoyi Shi has authored 35 papers receiving a total of 429 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 7 papers in Epidemiology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xiaoyi Shi's work include Ferroptosis and cancer prognosis (4 papers), Ion channel regulation and function (4 papers) and Mitochondrial Function and Pathology (3 papers). Xiaoyi Shi is often cited by papers focused on Ferroptosis and cancer prognosis (4 papers), Ion channel regulation and function (4 papers) and Mitochondrial Function and Pathology (3 papers). Xiaoyi Shi collaborates with scholars based in China, Belgium and Slovenia. Xiaoyi Shi's co-authors include Wenzhi Guo, Shuijun Zhang, Peihao Wen, Jiakai Zhang, Zhihui Wang, Shengli Cao, Hua Ye, Gongquan Li, Jie Pan and Dongyu Zhang and has published in prestigious journals such as PLoS ONE, Hepatology and Scientific Reports.

In The Last Decade

Xiaoyi Shi

34 papers receiving 425 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoyi Shi China 10 287 139 69 46 39 35 429
Shengli Cao China 11 239 0.8× 157 1.1× 72 1.0× 31 0.7× 16 0.4× 32 387
Yong Zou China 10 196 0.7× 82 0.6× 32 0.5× 26 0.6× 40 1.0× 16 448
Xurde M. Caravia Spain 10 244 0.9× 78 0.6× 46 0.7× 84 1.8× 77 2.0× 15 366
Zuo Wang China 11 242 0.8× 90 0.6× 123 1.8× 53 1.2× 17 0.4× 15 484
Shulin Wu China 6 343 1.2× 103 0.7× 79 1.1× 119 2.6× 14 0.4× 10 484
Jared T. Field Canada 8 199 0.7× 101 0.7× 133 1.9× 38 0.8× 33 0.8× 12 358
Li-Der Hsiao Taiwan 14 233 0.8× 75 0.5× 41 0.6× 39 0.8× 30 0.8× 14 418
Dongyuan Xu China 13 240 0.8× 150 1.1× 51 0.7× 23 0.5× 37 0.9× 42 516
Oriana Lo Re Czechia 17 433 1.5× 148 1.1× 119 1.7× 154 3.3× 34 0.9× 29 684
Mounia Boulberdaa France 11 287 1.0× 165 1.2× 26 0.4× 41 0.9× 84 2.2× 12 429

Countries citing papers authored by Xiaoyi Shi

Since Specialization
Citations

This map shows the geographic impact of Xiaoyi Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoyi Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoyi Shi more than expected).

Fields of papers citing papers by Xiaoyi Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoyi Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoyi Shi. The network helps show where Xiaoyi Shi may publish in the future.

Co-authorship network of co-authors of Xiaoyi Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoyi Shi. A scholar is included among the top collaborators of Xiaoyi Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoyi Shi. Xiaoyi Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Han, Qi Liu, Shengli Cao, et al.. (2025). Programmed cell death-related genes define distinct molecular subtypes and risk profiles in hepatocellular carcinoma. Scientific Reports. 15(1). 37117–37117. 1 indexed citations
2.
Gao, Jie, Xiaoyi Shi, Yaohui Sun, et al.. (2024). Deficiency of betaine-homocysteine methyltransferase activates glucose-6-phosphate dehydrogenase (G6PD) by decreasing arginine methylation of G6PD in hepatocellular carcinogenesis. Science China Life Sciences. 67(8). 1648–1665. 5 indexed citations
3.
Shi, Xiaoyi, Jiakai Zhang, Jie Gao, et al.. (2024). Melatonin attenuates liver ischemia-reperfusion injury via inhibiting the PGAM5-mPTP pathway. PLoS ONE. 19(10). e0312853–e0312853. 2 indexed citations
4.
Shi, Xiaoyi, Jiao Huang, Jiakai Zhang, et al.. (2023). Discovery of novel arylamide derivatives containing piperazine moiety as inhibitors of tubulin polymerisation with potent liver cancer inhibitory activity. Journal of Enzyme Inhibition and Medicinal Chemistry. 38(1). 2237701–2237701. 6 indexed citations
5.
Shi, Xiaoyi, et al.. (2023). SCD1 inhibits HBV replication by regulating autophagy under high lipid conditions. Virus Genes. 59(6). 801–816. 1 indexed citations
6.
7.
Dong, Yan, et al.. (2023). Clinical and genetic characteristics of 36 children with Joubert syndrome. Frontiers in Pediatrics. 11. 1102639–1102639. 4 indexed citations
8.
Shi, Xiaoyi, Ernesto Lopes Pinheiro-Júnior, Steve Peigneur, et al.. (2022). Design of New Potent and Selective Thiophene-Based KV1.3 Inhibitors and Their Potential for Anticancer Activity. Cancers. 14(11). 2595–2595. 5 indexed citations
9.
Shi, Xiaoyi, et al.. (2022). Bacterial survivors: evaluating the mechanisms of antibiotic persistence. Microbiology. 168(12). 9 indexed citations
10.
Shi, Xiaoyi, Ernesto Lopes Pinheiro-Júnior, Steve Peigneur, et al.. (2022). New Diarylamine KV10.1 Inhibitors and Their Anticancer Potential. Pharmaceutics. 14(9). 1963–1963. 5 indexed citations
11.
Shi, Xiaoyi, et al.. (2022). Identification and investigation of a novel NADP+-dependent secoisolariciresinol dehydrogenase from Isatis indigotica. Frontiers in Plant Science. 13. 1035121–1035121. 3 indexed citations
12.
Li, Jinjin, et al.. (2022). Isolongifolene alleviates liver ischemia/reperfusion injury by regulating AMPK-PGC1α signaling pathway-mediated inflammation, apoptosis, and oxidative stress. International Immunopharmacology. 113(Pt A). 109185–109185. 16 indexed citations
13.
Shi, Xiaoyi, et al.. (2022). [Clinical and genetic analysis of two patients with CHARGE syndrome due to de novo variants of CHD7 gene].. PubMed. 39(4). 387–391. 1 indexed citations
14.
Žegura, Bojana, Alja Štern, Matjaž Novak, et al.. (2021). 3D Pharmacophore-Based Discovery of Novel KV10.1 Inhibitors with Antiproliferative Activity. Cancers. 13(6). 1244–1244. 8 indexed citations
15.
Shi, Xiaoyi, Steve Peigneur, Tihomir Tomašič, et al.. (2021). Overcoming challenges of HERG potassium channel liability through rational design: Eag1 inhibitors for cancer treatment. Medicinal Research Reviews. 42(1). 183–226. 25 indexed citations
16.
Shi, Xiaoyi, et al.. (2021). Expression and crucial role of long non-coding RNA FGD5-AS1 in human cancers.. American Journal of Translational Research. 13(10). 10964–10976. 4 indexed citations
17.
Liu, Weifeng, Dongjing Yang, Jihua Shi, et al.. (2021). Caspase-1 Inhibitor Reduces Pyroptosis Induced by Brain Death in Kidney. Frontiers in Surgery. 8. 760989–760989. 6 indexed citations
18.
Hartung, Franziska, Xiaoyi Shi, Klaus Pfizenmaier, et al.. (2020). A Novel Anti-Kv10.1 Nanobody Fused to Single-Chain TRAIL Enhances Apoptosis Induction in Cancer Cells. Frontiers in Pharmacology. 11. 686–686. 20 indexed citations
19.
Gao, Jie, Huapeng Zhang, Yaohui Sun, et al.. (2020). Synaptopodin-2 promotes hepatocellular carcinoma metastasis via calcineurin-induced nuclear-cytoplasmic translocation. Cancer Letters. 482. 8–18. 13 indexed citations
20.
Wen, Peihao, Dongyu Wang, Jiakai Zhang, et al.. (2016). Kruppel-like factor 6 suppresses growth and invasion of hepatocellular carcinoma cells in vitro and in vivo. International Journal of Immunopathology and Pharmacology. 29(4). 666–675. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shengli Cao Breakdown of academic impact, for papers by Yong Zou Breakdown of academic impact, for papers by Xurde M. Caravia Breakdown of academic impact, for papers by Zuo Wang Breakdown of academic impact, for papers by Shulin Wu Breakdown of academic impact, for papers by Jared T. Field Breakdown of academic impact, for papers by Li-Der Hsiao Breakdown of academic impact, for papers by Dongyuan Xu Breakdown of academic impact, for papers by Oriana Lo Re Breakdown of academic impact, for papers by Mounia Boulberdaa
Rankless by CCL
2026